Literature DB >> 19563821

Study of patient's injuries by stingrays, lethal activity determination and cardiac effects induced by Himantura gerrardi venom.

Hadi Dehghani1, Mir Masoud Sajjadi, Hamid Rajaian, Javad Sajedianfard, Paria Parto.   

Abstract

Stingrays are common inhabitants in the northern waters of the Persian Gulf and Oman Sea. In the present study, the clinical aspects of injuries induced in three patients bitten by stingrays in Hormozgan province waters were first examined. The LD(50) of crude venom extract obtained from the most common stingray in Hormozgan province (Himantura gerrardi) was then estimated by up-and-down dosing and double dose methods in mice. Third and finally, the cardiac symptoms induced by injection of the extract from the venomous spines were evaluated in rats. Intense pain was noticed in all human cases. Redness was observed in two cases, and spasm and seizure were each recorded in only one case. LD(50) of the venom extract in mice was about 100 mg kg(-1). The observed cardiac symptoms in rats included an increase in pulse rate and various changes in electrocardiogram (ECG) parameters such as T and Q values, and PR and RR intervals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563821     DOI: 10.1016/j.toxicon.2009.06.023

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  Case Report: Iatrogenic Infection from Traditional Treatment of Stingray Envenomation.

Authors:  Bo Langhoff Hønge; Cecilie Blenstrup Patsche; Mads Mose Jensen; Frederik Schaltz-Buchholzer; Thomas Baad-Hansen; Christian Wejse
Journal:  Am J Trop Med Hyg       Date:  2018-01-18       Impact factor: 2.345

2.  Fibrinogenolytic and anticoagulant activities in the tissue covering the stingers of marine stingrays Dasyatis sephen and Aetobatis narinari.

Authors:  Kalainesan Rajesh Kumar; Rathinam Vennila; Shankar Kanchana; Muthuvel Arumugam; Thangavel Balasubramaniam
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.